Skip to main content

Table 2 Preoperative and intraoperative data

From: Total arterial revascularization in patients with acute myocardial infarction – feasibility and outcomes

Parameter SV group *
n = 152
TAR group *
n = 98
p-value
Antiplatelet therapy
 ASA 137 (93) 86 (91) 0.44
 Ticagrelor 9 (6.1) 10 (11) 0.20
 Prasugrel 3 (2.0) 3 (3.2) 0.57
 Clopidogrel 44 (30) 20 (22) 0.16
 DAPT 51 (34) 32 (33) 0.71
 Tirofiban 90 (60) 61 (65) 0.41
Vitamin K antagonists 6 (4.1) 1 (1.0) 0.082
Time interval symptom onset to operation (h)** 72 ± 5.1 72 ± 5.3 0.85
Grafts
 LIMA 147 (97) 98 (100) < 0.001
 RIMA 2 (1.3) 84 (86)
 Radial artery 0 18 (18)
Saphenous vein 152 (100) 0  
Coronary anastomoses
 Total 3.8 ± 1.1 3.6 ± 1.0 0.11
 Arterial grafts 1.5 ± 0.6 3.6 ± 1.0 < 0.001
 Venous grafts 2.3 ± 1.0 0 < 0.001
Target vessels
 LAD 151 (99) 98 (100) 0.42
 RCX 132 (89) 87 (89) 0.59
 RCA 116 (76) 80 (82) 0.32
Complete revascularization [n; %] 149 (99) 95 (97) 0.69
  1. Abbreviations: CABG coronary artery bypass grafting, DAPT dual antiplatelet therapy, LAD left anterior descending artery, LVEF left ventricular ejection fraction, NSTEMI non-ST-segment elevation myocardial infarction, PCI percutaneous coronary intervention, RCA right coronary artery, RCX Ramus circumflexus, SV saphenous vein grafts, STEMI ST-segment-elevation myocardial infarction, TAR total arterial revascularization
  2. aContinuous variables: mean ± SD; categorical variables: n (%)
  3. bMedian ± SD